218 related articles for article (PubMed ID: 9723711)
21. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
[TBL] [Abstract][Full Text] [Related]
22. Efficient isolation of mutant antigen presenting cell lines by functional selection using T cell clones.
Koarada S; Kubota E; Tokushima M; Naitoh K; Miyake K; Kimoto M
J Immunol Methods; 1995 Jun; 182(2):209-18. PubMed ID: 7790727
[TBL] [Abstract][Full Text] [Related]
23. Human duodenal epithelial cells constitutively express molecular components of antigen presentation but not costimulatory molecules.
Byrne B; Madrigal-Estebas L; McEvoy A; Carton J; Doherty DG; Whelan A; Feighery C; O'Donoghue DP; O'Farrelly C
Hum Immunol; 2002 Nov; 63(11):977-86. PubMed ID: 12392850
[TBL] [Abstract][Full Text] [Related]
24. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
25. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
[TBL] [Abstract][Full Text] [Related]
26. Molecular associations and microdomains in antigen-presenting cell-T-cell interactions.
Triantafilou K; Triantafilou M; Fernandez N
Crit Rev Immunol; 2000; 20(5):359-73. PubMed ID: 11145215
[TBL] [Abstract][Full Text] [Related]
27. Polyphenolic antioxidants inhibit peptide presentation by antigen-presenting cells.
Gong J; Chen SS
Int Immunopharmacol; 2003 Dec; 3(13-14):1841-52. PubMed ID: 14636833
[TBL] [Abstract][Full Text] [Related]
28. Functional evidence for the recognition of endogenous peptides by autoreactive T cell clones.
Rees AD; Lombardi G; Scoging A; Barber L; Mitchell D; Lamb J; Lechler R
Int Immunol; 1989; 1(6):624-30. PubMed ID: 2489049
[TBL] [Abstract][Full Text] [Related]
29. Human anti-mouse xenorecognition. Provision of noncognate interactions reveals plasticity of T cell repertoire.
Batten P; Heaton T; Fuller-Espie S; Lechler RI
J Immunol; 1995 Aug; 155(3):1057-65. PubMed ID: 7543511
[TBL] [Abstract][Full Text] [Related]
30. Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.
Mellins E; Arp B; Singh D; Carreno B; Smith L; Johnson AH; Pious D
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4785-9. PubMed ID: 2112748
[TBL] [Abstract][Full Text] [Related]
31. Mutations in specific I-A(k) alpha(2) and beta(2) domain residues affect surface expression.
Lang ML; Yadati S; Seeley ES; Nydam T; Wade TK; Gabriel JL; Yeaman G; Barisas BG; Wade WF
Int Immunol; 2000 Jun; 12(6):777-86. PubMed ID: 10837405
[TBL] [Abstract][Full Text] [Related]
32. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
33. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
[TBL] [Abstract][Full Text] [Related]
34. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
35. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
36. Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC-peptide conformation and T cell recognition.
Tate KM; Lee C; Edelman S; Carswell-Crumpton C; Liblau R; Jones PP
Int Immunol; 1995 May; 7(5):747-61. PubMed ID: 7547702
[TBL] [Abstract][Full Text] [Related]
37. CD45-positive cells of the retina and their responsiveness to in vivo and in vitro treatment with IFN-gamma or anti-CD40.
Gregerson DS; Yang J
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3083-93. PubMed ID: 12824255
[TBL] [Abstract][Full Text] [Related]
38. Truncation of the A alpha chain of MHC class II molecules results in inefficient antigen presentation to antigen-specific T cells.
Wade WF; Ward ED; Rosloniec EF; Barisas BG; Freed JH
Int Immunol; 1994 Oct; 6(10):1457-65. PubMed ID: 7826938
[TBL] [Abstract][Full Text] [Related]
39. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
Jaiswal AI; Dubey C; Swain SL; Croft M
Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
[TBL] [Abstract][Full Text] [Related]
40. Do antigenic drift residues in influenza hemagglutinins of the H3 subtype qualify as contact sites for MHC class II interaction?
Graham CM; Warren AP; Thomas DB
Int Immunol; 1992 Aug; 4(8):917-22. PubMed ID: 1358189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
